Extending the MIS BAIR randomised trial of BCG to prevent childhood allergy and infection [ 2016 - 2020 ]

Research Grant

Researchers: Prof Nigel Curtis (Principal investigator) ,  A/Pr Katie Flanagan ,  A/Pr Susan Donath ,  Prof Frank Shann ,  Prof Michael South
View all 6 related researchers

Brief description BCG (used till recently to prevent tuberculosis) is a potential low cost and readily available vaccine which could reduce the rates of allergy and infection in Australian children. We propose to extend our existing NHMRC-funded trial, which studies whether BCG vaccinatinon given at birth prevents the development food allergy, eczema and infection in the 1st year of life, to see if this effect continues until 5yrs of age. At this age, we can also see if BCG vaccination at birth prevents asthma.

Funding Amount $AUD 974,236.89

Funding Scheme Project Grants

Notes Standard Project Grant